scholarly journals Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Jingze Yang ◽  
Peng Wang ◽  
Tong Liu ◽  
Lin Lin ◽  
Lixiang Li ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Gut Microbiota ◽  
Intestinal Flora ◽  
Cell Number ◽  
Future Research ◽  
Pain Frequency ◽  
Ec Cells ◽  
Descending Colon ◽  
Irritable Bowel

Abstract Background Accumulating evidence supports the pivotal role of intestinal flora in irritable bowel syndrome (IBS). Serotonin synthesis by enterochromaffin (EC) cells is influenced by the gut microbiota and has been reported to have an interaction with IBS. The comparison between the microbiota of the caecal and colonic mucosa in IBS has rarely been studied. The aim of this study was to investigate the relationship between the gut microbiota, EC cells in caecum and descending colon, and diarrhoea-predominant IBS (IBS-D) symptoms. Results A total of 22 IBS-D patients and 22 healthy controls (HCs) were enrolled in our study. Hamilton anxiety (HAM-A) and Hamilton depression (HAM-D) grades increased significantly in IBS-D patients. In addition, the frequency of defecation in IBS-D patients was higher than that in HCs. Among the preponderant bacterial genera, the relative abundance of the Ruminococcus_torques_ group increased in IBS-D patients in caecum samples while Raoultella and Fusobacterium were less abundant. In the descending colon, the abundance of the Ruminococcus_torques_group and Dorea increased in IBS-D patients and Fusobacterium decreased. No difference was observed between the descending colon and caecum in regards to the mucosal-associated microbiota. The number of EC cells in the caecum of IBS-D patients was higher than in HCs and the expression of TPH1 was higher in IBS-D patients both in the caecum and in the descending colon both at the mRNA and protein level. Correlation analysis showed that the Ruminococcus_torques_group was positively associated with HAM-A, HAM-D, EC cell number, IBS-SSS, degree of abdominal pain, frequency of abdominal pain and frequency of defecation. The abundance of Dorea was positively associated with EC cell number, IBS-SSS, HAM-A, HAM-D and frequency of abdominal pain. Conclusions EC cell numbers increased in IBS-D patients and the expression of TPH1 was higher than in HCs. The Ruminococcus torques group and Dorea furthermore seem like promising targets for future research into the treatment of IBS-D patients.

scholarly journals Involvement of Mucosal Flora and Enterochromaffin Cell of Cecum and Descending Colon in Diarrhea-Predominant Irritable Bowel Syndrome

2020 ◽  
Author(s):  
Jingze Yang ◽  
Peng Wang ◽  
Tong Liu ◽  
Lin Lin ◽  
Lixiang Li ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Colonic Mucosa ◽  
Tryptophan Hydroxylase ◽  
Cell Number ◽  
Enterochromaffin Cell ◽  
Ec Cells ◽  
Descending Colon ◽  
Irritable Bowel ◽  
The Relationship

Abstract Background: The comparison between microbiota of cecal and colonic mucosa in irritable bowel syndrome (IBS) was rarely studied. In addition, enterochromaffin (EC) cell had interaction with IBS. The aim of this study was to investigate the relationship among gut microbiota, EC cell and diarrhea-predominant IBS (IBS-D) symptoms in cecum and descending colon. Methods: Biopsies from cecum and descending colon were taken during endoscopy withdrawal. We assessed EC cell numbers, expression of tryptophan hydroxylase 1 (TPH1) and microbial diversity.Results: Total of 22 IBS-D patients and 22 health controls (HCs) were enrolled. The relative abundance of Ruminococcus_torques_group (4.91% vs. 2.20%, P = 0.04763) of cecum increased in IBS-D, while Raoultella (1.58% vs. 1.76%, P = 0.03117) and Fusobacterium (0.12% vs. 1.66%, P = 0.01892) were less abundant. In descending colon, the relative abundances of Ruminococcus_torques_group (5.94% vs. 2.29%, P = 0.04183) and Dorea (2.68% vs. 1.14%, P = 0.04962) of IBS-D increased but Fusobacterium (1.52% vs. 1.89%, P = 0.0345) decreased. EC cells number in cecum of IBS-D was higher than that in HCs and TPH1 level of IBS-D was higher than that of HCs in cecum and descending colon. Correlation analysis showed that Ruminococcus_torques_group were positively associated with HAM-A (r= 0.66, P = 0.004), HAM-D (r= 0.61, P = 0.009), EC cell number (r= 0.49, P = 0.047), IBS-SSS (r= 0.65, P = 0.004), Degree of Abdominal Pain (r = 0.63, P = 0.007), Frequency of Abdominal Pain (r = 0.63, P = 0.007), Frequency of Defecation (r = 0.60, P = 0.011). The abundance of Dorea were positively associated with EC cell number (r = 0.57, P = 0.018), IBS-SSS (r = 0.52, P = 0.034), HAM-A (r = 0.72, P = 0.001), HAM-D (r = 0.59, P = 0.012), Frequency of Abdominal Pain (r = 0.67, P = 0.003).Conclusions: EC cells number increased in IBS-D patients and the expression of TPH1 was higher than HCs. In addition, our results suggested Ruminococcus_torques_group and Dorea may be targets for treatment of IBS-D but still need further studies.

scholarly journals Involvement of Mucosal Flora and Enterochromaffin Cell of Cecum and Descending Colon in Diarrhea-Predominant Irritable Bowel Syndrome

2021 ◽  
Author(s):  
Jingze Yang ◽  
Peng Wang ◽  
Tong Liu ◽  
Lin Lin ◽  
Lixiang Li ◽  
...  
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Correlation Analysis ◽  
Colonic Mucosa ◽  
Cell Number ◽  
Enterochromaffin Cell ◽  
Ec Cells ◽  
Descending Colon ◽  
Irritable Bowel ◽  
The Relationship

Abstract BackgroundThe comparison between microbiota of cecal and colonic mucosa in irritable bowel syndrome (IBS) was rarely studied. In addition, enterochromaffin (EC) cell had interaction with IBS. The aim of this study was to investigate the relationship among gut microbiota, EC cell and diarrhea-predominant IBS (IBS-D) symptoms in cecum and descending colon. ResultsTotal of 22 IBS-D patients and 22 health controls (HCs) were enrolled. The relative abundance of Ruminococcus_torques_group (4.91% vs. 2.20%, P = 0.04763) of cecum increased in IBS-D, while Raoultella (1.58% vs. 1.76%, P = 0.03117) and Fusobacterium (0.12% vs. 1.66%, P = 0.01892) were less abundant. In descending colon, the relative abundances of Ruminococcus_torques_group (5.94% vs. 2.29%, P = 0.04183) and Dorea (2.68% vs. 1.14%, P = 0.04962) of IBS-D increased but Fusobacterium (1.52% vs. 1.89%, P = 0.0345) decreased. EC cells number in cecum of IBS-D was higher than that in HCs and TPH1 level of IBS-D was higher than that of HCs in cecum and descending colon. Correlation analysis showed that Ruminococcus_torques_group were positively associated with HAM-A (r= 0.66, P = 0.004), HAM-D (r= 0.61, P = 0.009), EC cell number (r= 0.49, P = 0.047), IBS-SSS (r= 0.65, P = 0.004), Degree of Abdominal Pain (r = 0.63, P = 0.007), Frequency of Abdominal Pain (r = 0.63, P = 0.007), Frequency of Defecation (r = 0.60, P = 0.011). The abundance of Dorea were positively associated with EC cell number (r = 0.57, P = 0.018), IBS-SSS (r = 0.52, P = 0.034), HAM-A (r = 0.72, P = 0.001), HAM-D (r = 0.59, P = 0.012), Frequency of Abdominal Pain (r = 0.67, P = 0.003).ConclusionsEC cells number increased in IBS-D patients and the expression of TPH1 was higher than HCs. In addition, our results suggested Ruminococcus_torques_group and Dorea may be targets for treatment of IBS-D but still need further studies.

Gut Microbiome and Its Role in the Pathophysiology of Irritable Bowel Syndrome

2021 ◽  
Vol 51 (4) ◽  
Author(s):  
Giada De Palma ◽  
Premysl Bercik
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Gut Microbiota ◽  
Gut Microbiome ◽  
Gastrointestinal Disorder ◽  
Healthy Controls ◽  
Fecal Microbiome ◽  
Targeted Treatments ◽  
Irritable Bowel ◽  
And Function

Irritable bowel syndrome is the most common functional gastrointestinal disorder, affecting up to 9% individuals globally. Although the etiology of this syndrome is likely heterogenous, it presents with its hallmark symptoms of abdominal pain and altered intestinal motility. Moreover, it is considered to be a disorder of the gut-brain interaction, and the microbiome has often been implicated as a central player in its pathophysiology. Patients with irritable bowel syndrome display altered composition and function of the gut microbiota compared to healthy controls. Microbiome directed therapies, such as probiotics, antibiotics and fecal microbiome transplantation, appear to be beneficial for both gut symptoms and psychiatric comorbidities. This review aims to recapitulate the available literature on the microbiome contribution to the pathophysiology and symptoms presentation of irritable bowel syndrome, as well as the current literature on microbiome-targeted treatments for this disease.

Effectiveness of rifaximin in the treatment of abdominal pain at irritable bowel syndrome

2020 ◽  
Vol 0 (4) ◽  
pp. 22-28
Author(s):  
S. M. Tkach ◽  
A. E. Dorofeev ◽  
N. M. Mirzabaeva
Keyword(s):  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Irritable Bowel

scholarly journals Identification of potential biomarkers for abdominal pain in IBS patients by bioinformatics approach

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Zhongyuan Lin ◽  
Yimin Wang ◽  
Shiqing Lin ◽  
Decheng Liu ◽  
Guohui Mo ◽  
...  
Keyword(s):  
Gene Expression ◽  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Gastrointestinal Disease ◽  
Rectal Mucosa ◽  
Interaction Network ◽  
Enrichment Analysis ◽  
Functional Enrichment ◽  
Irritable Bowel ◽  
Potential Biomarkers

Abstract Background Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disease characterized by chronic abdominal discomfort and pain. The mechanisms of abdominal pain, as a relevant symptom, in IBS are still unclear. We aimed to explore the key genes and neurobiological changes specially involved in abdominal pain in IBS. Methods Gene expression data (GSE36701) was downloaded from Gene Expression Omnibus database. Fifty-three rectal mucosa samples from 27 irritable bowel syndrome with diarrhea (IBS-D) patients and 40 samples from 21 healthy volunteers as controls were included. Differentially expressed genes (DEGs) between two groups were identified using the GEO2R online tool. Functional enrichment analysis of DEGs was performed on the DAVID database. Then a protein–protein interaction network was constructed and visualized using STRING database and Cytoscape. Results The microarray analysis demonstrated a subset of genes (CCKBR, CCL13, ACPP, BDKRB2, GRPR, SLC1A2, NPFF, P2RX4, TRPA1, CCKBR, TLX2, MRGPRX3, PAX2, CXCR1) specially involved in pain transmission. Among these genes, we identified GRPR, NPFF and TRPA1 genes as potential biomarkers for irritating abdominal pain of IBS patients. Conclusions Overexpression of certain pain-related genes (GRPR, NPFF and TRPA1) may contribute to chronic visceral hypersensitivity, therefore be partly responsible for recurrent abdominal pain or discomfort in IBS patients. Several synapses modification and biological process of psychological distress may be risk factors of IBS.

scholarly journals Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review

2021 ◽  
Vol 14 ◽  
pp. 175628482199358
Author(s):  
Nikita Hanning ◽  
Adam L. Edwinson ◽  
Hannah Ceuleers ◽  
Stephanie A. Peters ◽  
Joris G. De Man ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Irritable Bowel Syndrome ◽  
Abdominal Pain ◽  
Barrier Function ◽  
Significant Proportion ◽  
Healthy Controls ◽  
Barrier Dysfunction ◽  
Irritable Bowel

Background and Aim: Irritable bowel syndrome (IBS) is a complex and heterogeneous disorder. Sensory, motor and barrier dysfunctions are the key physiological endophenotypes of IBS. Our aim is to review studies evaluating barrier dysfunction in adults and children with IBS, as well as to link those changes with IBS symptomatology and quality of life. Methods: A comprehensive and systematic review of multiple databases was performed up to March 2020 to identify studies comparing intestinal permeability in IBS patients with healthy controls. Both in vivo and in vitro studies were considered. Results: We identified 66 studies, of which 27 used intestinal probes to quantify barrier function. The prevalence of barrier dysfunction differed between PI-IBS (17–50%), IBS-D (37–62%) and IBS-C (4–25%). At a group level, permeability was increased compared with healthy controls in IBS-D (9/13 studies) and PI-IBS (4/4 studies), but only a minority of IBS-C (2/7 studies) and not in the only IBS-M study. All four studies in children with IBS demonstrated loss of barrier function. A heterogeneous set of tight junction genes were found to be altered in small and large intestines of adults with IBS, but these have not been evaluated in children. Positive associations were identified between barrier dysfunction and bowel disturbances (6/9 studies), abdominal pain (9/13 studies), overall symptom severity (1/6 studies), depression and anxiety (1/1 study) and quality of life (1/4 studies). Fecal slurry or supernatants of IBS patients were found to induce barrier disruption in animal models (5/6 studies). Conclusions: Barrier dysfunction is present in a significant proportion of adult and all pediatric IBS studies, especially in the IBS-D and PI-IBS subtype. The majority of studies indicated a positive association between loss of barrier function and symptoms such as abdominal pain and changes in the bowel function.

scholarly journals Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components

2021 ◽  
Vol 11 (1) ◽  
pp. 35
Author(s):  
Zahra A. Barandouzi ◽  
Joochul Lee ◽  
Kendra Maas ◽  
Angela R. Starkweather ◽  
Xiaomei S. Cong
Keyword(s):  
Irritable Bowel Syndrome ◽  
Gut Microbiota ◽  
Alpha Diversity ◽  
Diversity Indices ◽  
Cross Sectional Study ◽  
Caffeine Intake ◽  
Caffeine Consumption ◽  
Cross Sectional ◽  
Food Components ◽  
Irritable Bowel

The interplay between diet and gut microbiota has gained interest as a potential contributor in pathophysiology of irritable bowel syndrome (IBS). The purpose of this study was to compare food components and gut microbiota patterns between IBS patients and healthy controls (HC) as well as to explore the associations of food components and microbiota profiles. A cross-sectional study was conducted with 80 young adults with IBS and 21 HC recruited. The food frequency questionnaire was used to measure food components. Fecal samples were collected and profiled by 16S rRNA Illumina sequencing. Food components were similar in both IBS and HC groups, except in caffeine consumption. Higher alpha diversity indices and altered gut microbiota were observed in IBS compared to the HC. A negative correlation existed between total observed species and caffeine intake in the HC, and a positive correlation between alpha diversity indices and dietary fiber in the IBS group. Higher alpha diversity and gut microbiota alteration were found in IBS people who consumed caffeine more than 400 mg/d. Moreover, high microbial diversity and alteration of gut microbiota composition in IBS people with high caffeine consumption may be a clue toward the effects of caffeine on the gut microbiome pattern, which warrants further study.

Sign in / Sign up

Export Citation Format

Share Document